Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M410978200 on October 7, 2004

J. Biol. Chem., Vol. 279, Issue 51, 53145-53151, December 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/51/53145    most recent
M410978200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heitmeier, M. R.
Right arrow Articles by Maziasz, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heitmeier, M. R.
Right arrow Articles by Maziasz, T. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Cyclooxygenase-2 in Cytokine-induced {beta}-Cell Dysfunction and Damage by Isolated Rat and Human Islets*

Monique R. Heitmeier{ddagger}§, Colleen B. Kelly¶, Nancy J. Ensor{ddagger}, Kenneth A. Gibson{ddagger}, Karen G. Mullis{ddagger}, John A. Corbett¶, and Timothy J. Maziasz||

From the Departments of {ddagger}Cardiovascular and Metabolic Diseases and ||Arthritis and Inflammation, Pfizer Global Research and Development, St. Louis, Missouri 63017 and the Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri 63104

Type I diabetes mellitus is an autoimmune disease characterized by the selective destruction of the insulin-secreting {beta}-cell found in pancreatic islets of Langerhans. Cytokines such as interleukin-1 (IL-1), interferon-{gamma} (IFN-{gamma}), and tumor necrosis factor-{alpha} (TNF-{alpha}) mediate {beta}-cell dysfunction and islet degeneration, in part, through the induction of the inducible isoform of nitric-oxide synthase and the production of nitric oxide by {beta}-cells. Cytokines also stimulate the expression of the inducible isoform of cyclooxygenase, COX-2, and the production of prostaglandin E2 (PGE2) by rat and human islets; however, the role of increased COX-2 expression and PGE2 production in mediating cytokine-induced inhibition of islet metabolic function and viability has been incompletely characterized. In this study, we have shown that treatment of rat islets with IL-1{beta} or human islets with a cytokine mixture containing IL-1{beta} + IFN-{gamma} ± TNF-{alpha} stimulates COX-2 expression and PGE2 formation in a time-dependent manner. Co-incubation of rat and human islets with selective COX-2 inhibitors SC-58236 and Celecoxib, respectively, attenuated cytokine-induced PGE2 formation. However, these inhibitors failed to prevent cytokine-mediated inhibition of insulin secretion or islet degeneration. These findings indicate that selective inhibition of COX-2 activity does not protect rat and human islets from cytokine-induced {beta}-cell dysfunction and islet degeneration and, furthermore, that islet production of PGE2 does not mediate these inhibitory and destructive effects.


Received for publication, September 23, 2004

* This work was supported in part by National Institutes of Health Grants DK 52194 and DK 68839 (to J. A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Cardiovascular and Metabolic Diseases, Pfizer Global Research and Development, 700 Chesterfield Pkwy. West, Mail Code T2C, St. Louis, MO 63017. Tel.: 314-274-3890; Fax: 314-274-8948, E-mail: Monique.R.Heitmeier{at}Pfizer.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. J. Persaud, D. Muller, V. D. Belin, I. Kitsou-Mylona, H. Asare-Anane, A. Papadimitriou, C. J. Burns, G. C. Huang, S. A. Amiel, and P. M. Jones
The Role of Arachidonic Acid and Its Metabolites in Insulin Secretion From Human Islets of Langerhans
Diabetes, January 1, 2007; 56(1): 197 - 203.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Kitazawa, Y. Shibata, S. Hashimoto, Y. Ohizumi, and T. Yamakuni
Proinsulin C-Peptide Stimulates a PKC/I{kappa}B/NF-{kappa}B Signaling Pathway to Activate COX-2 Gene Transcription in Swiss 3T3 Fibroblasts
J. Biochem., June 1, 2006; 139(6): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. J. Collier, P. T. Fueger, H. E. Hohmeier, and C. B. Newgard
Pro- and Antiapoptotic Proteins Regulate Apoptosis but Do Not Protect Against Cytokine-Mediated Cytotoxicity in Rat Islets and {beta}-Cell Lines.
Diabetes, May 1, 2006; 55(5): 1398 - 1406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement